Bayerpaul Pharmaceutical Group has been granted a GMP-based operating license by the Food and Drug Administration for the production of Pharmaceutical raw materials and the following raw material are presently being manufactured on its production line.
- Mesalazine
- Favipiravir
- Acyclovir
- Lidocaine hydrochloride
- (Water for injection) WFI